Adderall and Mydayis[ten] are trade names for a combination drug identified as combined amphetamine salts ("MAS" products and solutions) containing four salts of amphetamine. The combination is composed of equal sections racemic amphetamine and dextroamphetamine, which provides a (three:one) ratio (by excess weight) among dextroamphetamine and